EQT, a private equity firm, agreed to acquire SPT Labtech, a manufacturer and designer of automated instruments and consumables for life science research, from Battery Ventures, a global, technology-focused investment firm, for $798m. “We are excited to work with SPT Labtech and make an acquisition in our prioritized Life Science Tools subsector. We have been following the company for a long time and are thrilled to now be able to partner with CEO David Newble and his team. We believe the combination of our unique industry expertise, including our external EQT Advisor Network and in-house digital team, position us to support the company on its next phase of growth and enhance its mission of ‘making a difference in human health in everything we do’," Michael Bauer, EQT Partner and Global Co-Head of the Healthcare Team.